发明名称 Organic compounds
摘要 The invention relates to compounds and methods of treatment relating to nicotinic receptor antagonists. For example, the compounds and methods of treatment function block the activity of certain acetylcholine receptors and subtypes therein, and are useful treating diseases and conditions mediated by nicotinic receptor stimulation, e.g., small cell lung cancer.
申请公布号 US9469625(B2) 申请公布日期 2016.10.18
申请号 US201214128378 申请日期 2012.06.22
申请人 INTRA-CELLULAR THERAPIES, INC. 发明人 Li Peng;Peng Youyi;Tomesch John;Wennogle Lawrence P.;Zhang Qiang
分类号 A61K31/445;C07D401/12;A61K31/454;A61K31/4745;A61K31/506;A61K33/24;A61K45/06 主分类号 A61K31/445
代理机构 Hoxie & Associates LLC 代理人 Hoxie & Associates LLC
主权项 1. A compound of Formula I: wherein R1 is halogen, —SO2NH2, or —COOH; R2 is halogen, —SO2NH2, or —COOH, or H; Y and Z are independently a bond or —CH2—; X is N or CR6; R3 and R6 are independently H, phenyl, tolyl, ethyl or propyl; R5 is independently H, phenyl, tolyl, or lower alkyl; R4 is lower alkyl, or R4 is not present; in free or pharmaceutically acceptable salt form; provided that when R4 is lower alkyl, the compound forms a quaternary ammonium salt and there is an associated pharmaceutically acceptable anion present.
地址 New York NY US